Ghrelin, MicroRNAs, and Critical Limb Ischemia: Hungering for a Novel Treatment Option
Critical limb ischemia (CLI) is the most severe manifestation of peripheral artery disease. It is characterized by chronic pain at rest, skin ulcerations, and gangrene tissue loss. CLI is a highly morbid condition, resulting in a severely diminished quality of life and a significant risk of mortalit...
Main Authors: | Joshua P. H. Neale, James T. Pearson, Rajesh Katare, Daryl O. Schwenke |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2017-12-01
|
Series: | Frontiers in Endocrinology |
Subjects: | |
Online Access: | http://journal.frontiersin.org/article/10.3389/fendo.2017.00350/full |
Similar Items
-
Ghrelin and vascular protection
by: James T Pearson, et al.
Published: (2019-09-01) -
The Effect of MicroRNA-126 Mimic Administration on Vascular Perfusion Recovery in an Animal Model of Hind Limb Ischemia
by: Panagiotis Theofilis, et al.
Published: (2021-08-01) -
Autologous Peripheral Blood Mononuclear Cells for Limb Salvage in Diabetic Foot Patients with No-Option Critical Limb Ischemia
by: Alessia Scatena, et al.
Published: (2021-05-01) -
Effects of Ghrelin on Testicular Ischemia/Reperfusion-Induced Injury
by: Majid Taati, et al.
Published: (2016-02-01) -
Stem-cell therapies in critical limb ischemia
by: Sergiu Visnevschi, et al.
Published: (2021-03-01)